Estradiol Valerate/Norethindrone

戊酸雌二醇/炔诺酮

Report date: 2023/06/09 18:16:52

Base Information

Drug NameEstradiol Valerate/Norethindrone
Drug Alias NameClimesse
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptors agonistsProgesterone receptor agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsOestrogen deficiency symptomsVasomotor symptomVulvar and vaginal atrophy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Estradiol ValerateNorethindrone
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharmaceuticals Uk Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharmaceuticals Uk LtdZhejiang Xianju Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOestrogen deficiency symptomsVasomotor symptomVulvar and vaginal atrophy +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A